 PHILADELPHIA, Sept. 26, 2022 GLOBE NEWSWIRE -- Passage Bio, Inc. NASDAQ: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today announced that Simona King, chief financial officer of Passage Bio, will present at the upcoming Chardan Genetic Medicines Conference being held from October 3-4, 2022 in New York City. 